Related Experiment Video
Updated: May 16, 2026

Cell-based Assay to Study Antibody-mediated Tau Clearance by Microglia
Published on: November 9, 2018
Antioxidants as immunomodulators for Tau and Amyloid-β in Alzheimer's disease
Subashchandrabose Chinnathambi1, Nagaraj Rangappa1, Madhura Chandrashekar1
1Department of Neurochemistry, National Institute of Mental Health and Neuro Sciences Hospital (NIMHANS), Institute of National Importance, Bangalore, Karnataka, India.
Abstract:
Alzheimer's Disease is a progressive neurodegenerative disorder driven by oxidative stress, neuroinflammation, and pathological protein aggregation, such as Tau tangles and Amyloid-beta plaques. These processes disrupt neuronal integrity, contributing to cognitive decline. Dietary antioxidants, including phenolic compounds, omega-3 fatty acids, carotenoids, and isothiocyanates, have shown significant potential in mitigating these pathological mechanisms. They neutralize free radicals, reduce Tau hyperphosphorylation, inhibit Amyloid-beta aggregation, and alleviate inflammation, offering neuroprotection. Nutrient-rich diets, such as the Mediterranean, MIND, and Indian traditional diets, rich in these bioactive compounds, are associated with enhanced brain health and a reduced risk of AD progression. This review highlights the multifaceted role of antioxidants in preventing and managing AD while emphasizing the need for continued research to optimize their therapeutic potential and integration into daily nutrition.
Related Concept Videos
Alzheimer's Disease: Treatment
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
Alzheimer Disease ll: Pathophysiology
